Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors-Reference-Cited by-同舟云学术

Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors

Published:2014-11-26 Issue:2 Volume:56 Page:305-314
ISSN:0449-3060
Container-title:Journal of Radiation Research
language:en
Short-container-title:

Author:

Fujiwara Masateru,Isohashi Fumiaki,Mabuchi Seiji,Yoshioka Yasuo,Seo Yuji,Suzuki Osamu,Sumida Iori,Hayashi Kazuhiko,Kimura Tadashi,Ogawa Kazuhiko

Publisher

Oxford University Press (OUP)

Subject

Health, Toxicology and Mutagenesis,Radiology, Nuclear Medicine and imaging,Radiation

Link

http://academic.oup.com/jrr/article-pdf/56/2/305/23533962/rru101.pdf

Reference30 articles.

1. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study;Lanciano;J Clin Oncol,2005

2. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials;Vale;J Clin Oncol,2008

3. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule;Toita;Gynecol Oncol,2012

4. Feasibility and acute toxicity of concurrent chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066);Toita;Int J Gynecol Cancer,2012

5. Antitumor activity of a new platinum compound (glycolate o,o') diammineplatinum (II) (254-S), against non-small cell lung carcinoma grown in a human tumor clonogenic assay system;Kanzawa;Anticancer Res,1988

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and efficacy test of a survival prediction model for locally advanced cervical cancer based on anti-angiogenesis;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-06

2. Carcinoma cervix: A single institute experience from Kashmir, Northern India;Journal of Cancer Research and Therapeutics;2023

3. A phase III randomized, controlled trial of nedaplatin versus cisplatin concurrent chemoradiotherapy in patients with cervical cancer;ESMO Open;2022-10

4. Clinical Efficacy of Cervical Core Strengthening Exercise in the Treatment of Cervicogenic Headache;Rehabilitation Medicine;2022-06-01

5. Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Patients With Stage IIB-IVA Cervical Cancer: A Randomized Phase III Trial;Frontiers in Oncology;2022-02-02